Cambridge Investment Research Advisors’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $250K | Hold |
27,432
| – | – | ﹤0.01% | 3135 |
|
|
2025
Q1 | $218K | Sell |
27,432
-400
| -1% | -$3.18K | ﹤0.01% | 3133 |
|
|
2024
Q4 | $151K | Sell |
27,832
-716
| -3% | -$3.89K | ﹤0.01% | 3254 |
|
|
2024
Q3 | $206K | Sell |
28,548
-870
| -3% | -$6.28K | ﹤0.01% | 3134 |
|
|
2024
Q2 | $319K | Sell |
29,418
-1,937
| -6% | -$21K | ﹤0.01% | 2656 |
|
|
2024
Q1 | $588K | Sell |
31,355
-1,918
| -6% | -$36K | ﹤0.01% | 2154 |
|
|
2023
Q4 | $721K | Sell |
33,273
-1,800
| -5% | -$39K | ﹤0.01% | 1883 |
|
|
2023
Q3 | $722K | Sell |
35,073
-500
| -1% | -$10.3K | ﹤0.01% | 1789 |
|
|
2023
Q2 | $1.67M | Sell |
35,573
-666
| -2% | -$31.3K | 0.01% | 1283 |
|
|
2023
Q1 | $1.52M | Sell |
36,239
-192
| -0.5% | -$8.06K | 0.01% | 1301 |
|
|
2022
Q4 | $1.39M | Buy |
+36,431
| New | +$1.39M | 0.01% | 1299 |
|
|
2020
Q1 | – | Sell |
-3,477
| Closed | -$251K | – | 2448 |
|
|
2019
Q4 | $251K | Buy |
3,477
+1,168
| +51% | +$84.3K | ﹤0.01% | 2032 |
|
|
2019
Q3 | $324K | Buy |
2,309
+274
| +13% | +$38.4K | ﹤0.01% | 1764 |
|
|
2019
Q2 | $373K | Buy |
+2,035
| New | +$373K | ﹤0.01% | 1620 |
|